Filteren op Last updated date SelectNaVoorFrom - To Date Einddatum Deze week Deze maand Afgelopen week Afgelopen maand Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Laat dit veld leeg Filter Resultaten (3838) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Laat dit veld leeg Esmya: new measures to minimise risk of rare but serious liver injury 8 augustus 2018Press releaseHuman Update on review of recalled valsartan medicines: preliminary assessment of possible risk to patients 2 augustus 2018Press releaseHuman Brexit preparedness: EMA to further temporarily scale back and suspend activities 1 augustus 2018Press releaseCorporateBrexit Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 23-26 July 2018 Sixteen medicines recommended for approval, including two orphans 27 juli 2018NewsHuman New medicine for hereditary rare disease 27 juli 2018Press releaseHuman Two new paediatric-use marketing authorisations recommended by CHMP 27 juli 2018Press releaseHuman EMA restricts use of prostate cancer medicine Xofigo 27 juli 2018Press releaseHuman IT systems unavailable from 27 to 30 July 2018 25 juli 2018NewsCorporate Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 17–19 July 2018 20 juli 2018Press releaseVeterinary EU and Japan reinforce their collaboration on inspections of medicine manufacturers 18 juli 2018Press releaseCorporateCompliance and inspections 1 … 117 118 119 120 121 Page 121 of 384 122 123 124 125 … 384
Esmya: new measures to minimise risk of rare but serious liver injury 8 augustus 2018Press releaseHuman
Update on review of recalled valsartan medicines: preliminary assessment of possible risk to patients 2 augustus 2018Press releaseHuman
Brexit preparedness: EMA to further temporarily scale back and suspend activities 1 augustus 2018Press releaseCorporateBrexit
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 23-26 July 2018 Sixteen medicines recommended for approval, including two orphans 27 juli 2018NewsHuman
Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 17–19 July 2018 20 juli 2018Press releaseVeterinary
EU and Japan reinforce their collaboration on inspections of medicine manufacturers 18 juli 2018Press releaseCorporateCompliance and inspections